
NASDAQ:PEP
This summary was created by AI, based on 9 opinions in the last 12 months.
PepsiCo (PEP) is facing numerous challenges as it contends with rising demand for weight loss drugs, particularly GLP-1 medications, which are impacting consumer behavior, especially among younger demographics who are increasingly conscious of health. The company's North American business appears to be weakening, evidenced by recent downgrades and a notable decline in demand, particularly when compared to rivals like Coca-Cola. Although PepsiCo reported strong numbers last quarter, the recent market rotation has seen significant price adjustments, leading some experts to view current share prices as a potential buying opportunity. Additionally, despite the struggles, PepsiCo maintains a solid Frito-Lay snack division and offers an attractive 4% dividend yield, which some analysts find appealing amid the current volatility in the consumer staples sector.
He expects a great report from them on Thursday, because their snack business given them more consumer exposure than Coke has. Their last quarter was fine, but the market yawn from being bored with consumer staples. He bets their business is accelerating.
Allan Tong’s Discover Picks Analysts such as Jim Cramer would buy Pepsi stock now as the number of Covid cases could rise as the weather turns colder and more people stay at home to snack. Analysts expects its EPS to reach $1.50, which would return to last year’s levels. Pepsi pays a dividend just under 3%. The trailing PE has ballooned from 15.62x last December to the current 26.85x, which will give some investors pause. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.
There is a lot of pressure on carbonated beverages. It’s shrinking year-over-year. This has transitioned away better than Coca-Cola (KO-N) has. More than 50% of revenues comes from non-carbonated beverages. They have over 20 brands that generate over $1 billion a year. He would consider this if it were cheaper. Trading at over 20X Price to Earnings.